Study of the Investigational MS Drug Evobrutinib Has Encouraging Results,

It’s currently undergoing clinical trials for safety and efficacy, and new results from a phase 2 study were presented on April 18 during the 2021 annual …, It’s currently undergoing clinical trials for safety and efficacy, and new results from a phase 2 study were presented on April 18 during the 2021 annual …, Read More

Scroll to Top